EQT Life Sciences
33 portfolio companies · 6 on the map · $945.6M raised · 4 cities
Portfolio map
6 EQT Life Sciences portfolio companies on the map.
Portfolio companies

ONWARD Medical
Eindhoven
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Medical Equipment Manufacturing$314.7MEst. 2014
Xeltis
Eindhoven
Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.
Medical Device$198.3MEst. 2006
ViCentra
Utrecht
ViCentra has developed an insulin pump for diabetes patients.
Medical Equipment Manufacturing$193.9MEst. 2013
PanTera
Mol
Mol-based · biotech.
Biotech$134MEst. 2022
Onera Health
Eindhoven
Onera Health is a global leader in sleep diagnostics and monitoring.
Medical Equipment Manufacturing$57MEst. 2017
Ariceum Therapeutics
Berlin
Ariceum Therapeutics is a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. The name Ariceum is an anagram of ‘Marie Curie’ whose discovery of radium and polonium have been huge contributions to finding treatments for cancer. Ariceum’s lead targeted systemic radiopharmaceutical candidate, SSO110 (“satoreotide”) labelled with Lutetium-177 (177Lu) and Actinium-255 (255Ac) is an antagonist of the somatostatin type 2 (SSTR2) receptor which is overexpressed in aggressive neuroe
Biotech$47.8MEst. 2021
More portfolio companies
27 more EQT Life Sciences investments we track beyond the map.
TubulisMunich · Series C
QurAlisCambridge · Series B
DNA ScriptLe Kremlin-bicêtre · Series C
Atalanta TherapeuticsBoston · Series B
Shinobi TherapeuticsSouth San Francisco · Series A
AstronauTxReading · Series A
Noema PharmaBasel · Series B
Cardior PharmaceuticalsHanover · Series B
Binx HealthBoston · Series F
ImCheck TherapeuticsMarseille · Series C
Egle TherapeuticsParis · Series A
T-knifeBerlin · Series B
Sequana MedicalZürich · Post-IPO Debt
Arvelle TherapeuticsBasel · Series A
Neuros MedicalWilloughby · Series D
Mint SolutionsAmsterdam · Series B
NeuraviGalway · Series B
LuxendoHeidelberg · Series A
Kuros BiosciencesSchlieren · Post-IPO Equity
NexstimHelsinki · Venture
Harvest AutomationBillerica · Series C
IlluminOss MedicalEast Providence · Series C
Sapiens Steering Brain StimulationMunich · Series A
Isto TechnologiesSt Louis · Series E
BMEYEAmsterdam · Series A
MendorEspoo · Series B
BioProcessorsBerkeley · Series C
Portfolio map
6 EQT Life Sciences portfolio companies on the map.